Skip to main content

Research Repository

Advanced Search

All Outputs (7)

O26 Testing an intervention to reduce fatigue impact in inflammatory arthritis: Design and outcomes of a single-arm feasibility study (2021)
Journal Article
Bridgewater, S., Lomax, J., Abbott, B., Adams, J., Berry, A., Creanor, S., …Dures, E. (2021). O26 Testing an intervention to reduce fatigue impact in inflammatory arthritis: Design and outcomes of a single-arm feasibility study. Rheumatology, 60(S1), Article keab246.025. https://doi.org/10.1093/rheumatology/keab246.025

Background/Aims Patients with inflammatory arthritis report that fatigue can be a challenging symptom to manage, with little support available. In response, we developed a brief one-to-one cognitive-behavioural manualised intervention, delivered by r... Read More about O26 Testing an intervention to reduce fatigue impact in inflammatory arthritis: Design and outcomes of a single-arm feasibility study.

Identifying preliminary domains to detect and measure rheumatoid arthritis flares: Report of the OMERACT 10 RA Flare Workshop (2011)
Journal Article
Woodworth, T. G., Strand, V., Sanderson, T. C., Pohl, C., Montie, P., May, J. E., …Hewlett, S. (2011). Identifying preliminary domains to detect and measure rheumatoid arthritis flares: Report of the OMERACT 10 RA Flare Workshop. Journal of Rheumatology, 38(8), 1751-1758. https://doi.org/10.3899/jrheum.110401

Background. While disease flares in rheumatoid arthritis (RA) are a recognized aspect of the disease process, there is limited formative research to describe them. Methods. The Outcome Measures in Rheumatology Clinical Trials (OMERACT) RA Flare Defin... Read More about Identifying preliminary domains to detect and measure rheumatoid arthritis flares: Report of the OMERACT 10 RA Flare Workshop.

OMERACT 10 patient perspective virtual campus: Valuing health; measuring outcomes in rheumatoid arthritis fatigue, RA sleep, arthroplasty, and systemic sclerosis; and clinical significance of changes in health (2011)
Journal Article
Dworkin, R. H., Furst, D. E., Singh, J. A., Wells, G. A., Harrison, M. J., Boonen, A., …Hewlett, S. (2011). OMERACT 10 patient perspective virtual campus: Valuing health; measuring outcomes in rheumatoid arthritis fatigue, RA sleep, arthroplasty, and systemic sclerosis; and clinical significance of changes in health. Journal of Rheumatology, 38(8), 1728-1734. https://doi.org/10.3899/jrheum.110393

This workshop reviewed progress in a number of areas related to patient perspective outcomes that were not specifically included within other areas of the program. A substantial review of the work of the valuing health outcomes group (the "QALY" work... Read More about OMERACT 10 patient perspective virtual campus: Valuing health; measuring outcomes in rheumatoid arthritis fatigue, RA sleep, arthroplasty, and systemic sclerosis; and clinical significance of changes in health.

Patient perspective: Choosing or developing instruments (2011)
Journal Article
Osborne, R. H., Kirwan, J. R., Fries, J. F., & Hewlett, S. (2011). Patient perspective: Choosing or developing instruments. Journal of Rheumatology, 38(8), 1716-1719. https://doi.org/10.3899/jrheum.110390

Previous Outcome Measures in Rheumatology (OMERACT) meetings recognized that patients view outcomes of intervention from a different perspective. This preconference position paper briefly sets out 2 patient-reported outcome (PRO) instrument approache... Read More about Patient perspective: Choosing or developing instruments.

Patient perspective workshop: Moving towards OMERACT guidelines for choosing or developing instruments to measure patient-reported outcomes (2011)
Journal Article
Leong, A. L., Sanderson, T. C., Van De Laar, M. A., Osborne, R. H., Fries, J. F., Kirwan, J. R., …Richards, P. (2011). Patient perspective workshop: Moving towards OMERACT guidelines for choosing or developing instruments to measure patient-reported outcomes. Journal of Rheumatology, 38(8), 1711-1715. https://doi.org/10.3899/jrheum.110391

The workshop Choosing or Developing Instruments held at the Outcome Measures in Rheumatology (OMERACT) 10 meeting was designed to help participants think about the underlying methods of instrument development. Conference pre-reading material and 3 br... Read More about Patient perspective workshop: Moving towards OMERACT guidelines for choosing or developing instruments to measure patient-reported outcomes.

Developing a standardized definition for disease "flare" in rheumatoid arthritis (OMERACT 9 special interest group) (2009)
Journal Article
Alten, R. E., Strand, C. V., Furst, D. E., Witter, J. P., Rahman, M. U., May, J. E., …Boers, M. (2009). Developing a standardized definition for disease "flare" in rheumatoid arthritis (OMERACT 9 special interest group). Journal of Rheumatology, 36(10), 2335-2341. https://doi.org/10.3899/jrheum.090369

Objective. Traditional outcome measures in randomized controlled trials (RCT) include well-established response criteria as well as ACR EULAR responses using Disease Activity Score 44 (DAS44)/DAS28 to assess improvement; however, a measure to assess... Read More about Developing a standardized definition for disease "flare" in rheumatoid arthritis (OMERACT 9 special interest group).

Progress on incorporating the patient perspective in outcome assessment in rheumatology and the emergence of life impact measures at OMERACT 9 (2009)
Journal Article
Sanderson, T. C., Nicklin, J., March, L. M., Wells, G. A., Tugwell, P. S., Kirwan, J. R., …Welch, V. (2009). Progress on incorporating the patient perspective in outcome assessment in rheumatology and the emergence of life impact measures at OMERACT 9. Journal of Rheumatology, 36(9), 2071-2076. https://doi.org/10.3899/jrheum.090360

The Patient Perspective Workshop included over 100 researchers and 18 patient participants from 8 countries. Following preconference reading and short plenary presentations, breakout groups considered work undertaken on measurement of sleep, assessin... Read More about Progress on incorporating the patient perspective in outcome assessment in rheumatology and the emergence of life impact measures at OMERACT 9.